RS

Rajani Shailesh Kulkarni

Active Director Director DIN 09786281
DIN 09786281 First appointment Nov 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajani Shailesh Kulkarni

Data last updated:

Rajani Shailesh Kulkarni is a Director at Medicsface Software Private Limited (since 2022). The company operates in Pharma.

DIN 09786281
Primary Designation Director
Industry Pharma
First Appointment 10 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicsface Software Private Limited U24100GA2022PTC015605
Director10 Nov 20222022Active

Board colleagues of Rajani Shailesh Kulkarni

NameDINCompanyDesignation
Faria Nicole Liz09527653Medicsface Software Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medicsface Software Private Limited
Premium access

Shareholding and investment profile for Rajani Shailesh Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajani Shailesh Kulkarni

Rajani Shailesh Kulkarni currently holds 1 directorship: Medicsface Software Private Limited (Director, since 10 Nov 2022).

Rajani Shailesh Kulkarni was first appointed on 10 Nov 2022 as Director at Medicsface Software Private Limited.

The current boards of Rajani Shailesh Kulkarni's companies include Faria Nicole Liz (Medicsface Software Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available